Prevalence of Contraindications to Nirmatrelvir-Ritonavir among Hospitalized Patients with COVID-19 at Risk for Progression to Severe Disease

Nicolas Hoertel; David R. Boulware; Marina Sánchez-Rico; Anita Burgun; Frédéric Limosin

doi:10.1001/jamanetworkopen.2022.42140

Prevalence of Contraindications to Nirmatrelvir-Ritonavir among Hospitalized Patients with COVID-19 at Risk for Progression to Severe Disease

Nicolas Hoertel
, David R. Boulware
, Marina Sánchez-Rico
, Anita Burgun
, Frédéric Limosin

Medicine - Infectious Disease and International Medicine

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Original language	English (US)
Article number	e2242140
Journal	JAMA Network Open
Volume	5
Issue number	11
DOIs	https://doi.org/10.1001/jamanetworkopen.2022.42140
State	Published - Nov 15 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1001/jamanetworkopen.2022.42140

Find It

Find It at U of M Libraries

Cite this

@article{c0077245bccc4b2f9df6b0be16bcf17e,

title = "Prevalence of Contraindications to Nirmatrelvir-Ritonavir among Hospitalized Patients with COVID-19 at Risk for Progression to Severe Disease",

author = "Nicolas Hoertel and Boulware, \{David R.\} and Marina S{\'a}nchez-Rico and Anita Burgun and Fr{\'e}d{\'e}ric Limosin",

year = "2022",

month = nov,

day = "15",

doi = "10.1001/jamanetworkopen.2022.42140",

language = "English (US)",

volume = "5",

journal = "JAMA Network Open",

issn = "2574-3805",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Prevalence of Contraindications to Nirmatrelvir-Ritonavir among Hospitalized Patients with COVID-19 at Risk for Progression to Severe Disease

AU - Hoertel, Nicolas

AU - Boulware, David R.

AU - Sánchez-Rico, Marina

AU - Burgun, Anita

AU - Limosin, Frédéric

PY - 2022/11/15

Y1 - 2022/11/15

UR - https://www.scopus.com/pages/publications/85142400860

UR - https://www.scopus.com/pages/publications/85142400860#tab=citedBy

U2 - 10.1001/jamanetworkopen.2022.42140

DO - 10.1001/jamanetworkopen.2022.42140

M3 - Article

C2 - 36378313

AN - SCOPUS:85142400860

SN - 2574-3805

VL - 5

JO - JAMA Network Open

JF - JAMA Network Open

IS - 11

M1 - e2242140

ER -

Prevalence of Contraindications to Nirmatrelvir-Ritonavir among Hospitalized Patients with COVID-19 at Risk for Progression to Severe Disease

UN SDGs

Publisher link

Find It

Other files and links

Cite this